City Therapeutics(CTY)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CTY City Therapeutics

已收盘 11-11 16:00:00 EST

17.01

-2.61

-13.30%

盘后17.01

+0.000.00%

19:30 EST

最高21.31	最低16.21	成交量45.87万
今开19.63	昨收19.62	日振幅25.99%
总市值8.56亿	流通市值1.65亿	总股本5,033万
成交额874.41万	换手率4.72%	流通股本972.22万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CTY","market":"US","secType":"STK","nameCN":"City Therapeutics","latestPrice":17.01,"timestamp":1794430800000,"preClose":19.62,"halted":0,"volume":458677,"hourTrading":{"tag":"盘后","latestPrice":17.01,"preClose":17.01,"latestTime":"19:30 EST","volume":15,"amount":256.98,"timestamp":1794443400798,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.13302752293577977,"floatShares":9722237,"shares":50332299,"eps":-1.742,"marketStatus":"已收盘","change":-2.61,"latestTime":"11-11 16:00:00 EST","open":19.63,"high":21.3099,"low":16.21,"amount":8744068.340621,"amplitude":0.259934,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-1.742,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1794474000000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1792123200000,"exchange":"NASDAQ","adjPreClose":19.62,"postHourTrading":{"tag":"盘后","latestPrice":17.01,"preClose":17.01,"latestTime":"19:30 EST","volume":15,"amount":256.98,"timestamp":1794443400798,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.475236},"requestUrl":"/m/hq/s/CTY/tweets","defaultTab":"tweets","newsList":[{"id":"1157759837","title":"别只盯着 Anthropic：生物科技公司正悄然主导 IPO 市场","url":"https://stock-news.laohu8.com/highlight/detail?id=1157759837","media":"老虎资讯综合","labels":["EditorSelect"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1157759837?lang=zh_cn&edition=full","pubTime":"2026-10-25 11:17","pubTimestamp":1792898274,"startTime":"0","endTime":"0","summary":"City Therapeutics 于 10 月 16 日上市首日上涨近 30%，尽管此时整体市场表现疲弱。史密斯表示，许多公司更倾向于暂时观望，因为大多数拟上市企业都在等待当前市场波动结束、美国中期选举过去，以及 Anthropic 完成 IPO 之后再采取行动。《华尔街日报》报道称，一份 Anthropic IPO 申报文件草案显示，该公司在 2026 年上半年亏损超过 800 亿美元。不过，就目前而言，生物科技投资者似乎并没有受到 IPO 市场低迷的影响。","market":"us","thumbnail":"https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/3153c88188d79bb8182b93c4fdd43636"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"EditorSelect","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CTY","IPO002","LYCA","IAM","ANT","TRXB","RTSN"],"isVideo":false,"video":null,"gpt_icon":1},{"id":"2676754894","title":"RNAi药物开发商City纳斯达克上市：市值11亿美元 路演PPT曝光","url":"https://stock-news.laohu8.com/highlight/detail?id=2676754894","media":"雷递网","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676754894?lang=zh_cn&edition=full","pubTime":"2026-10-17 09:25","pubTimestamp":1792200304,"startTime":"0","endTime":"0","summary":"RNAi药物开发商City Therapeutics Inc(股票代码：“CTY”）昨日在美国纳斯达克上市。","market":"us","thumbnail":"https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261017/6392782587904902396083702.jpeg","type":0,"news_type":0,"thumbnails":["https://leidinews-1256465536.cos.ap-chengdu.myqcloud.com/u_News/20261017/6392782587904902396083702.jpeg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.leinews.com/n35423/detail.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"leinews_highlight","symbols":["CTY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676516184","title":"美股异动 | 生物技术公司City Therapeutics(CTY.US)登陆美股市场 开盘后涨近24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676516184","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676516184?lang=zh_cn&edition=full","pubTime":"2026-10-17 00:00","pubTimestamp":1792166400,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，周五，City Therapeutics登陆美股市场，截至发稿，该股涨近24%，报22.315美元。City Therapeutics是一家总部位于美国马萨诸塞州剑桥市的临床阶段生物技术公司，成立于2023年，专注于开发新一代RNA干扰疗法，通过抑制与疾病相关的特定蛋白质表达，治疗具有重大未满足医疗需求的疾病。公司由RNAi领域资深专家创立，联合创始人兼执行董事长John Maraganore曾担任RNAi制药先驱Alnylam的首席执行官。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1508627.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","BK4539","CTY","WDNA","BK4139","HELX","LENZ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674851717","title":"富达、Arch站台，RNAi新锐City Therapeutics(CTY.US)冲刺美股IPO，拟募资至多1.85亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2674851717","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674851717?lang=zh_cn&edition=full","pubTime":"2026-10-09 20:23","pubTimestamp":1791548622,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["REDS","IPOS","BK4539","BK4007","BK4127","KCE","BK4139","CTY","LENZ","FRHC"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.citytx.com","stockEarnings":[{"period":"1week","weight":0.0278},{"period":"1month","weight":0.09},{"period":"ytd","weight":0.09}],"compareEarnings":[{"period":"1week","weight":-0.0059},{"period":"1month","weight":-0.0368},{"period":"3month","weight":-0.0292},{"period":"6month","weight":0.0023},{"period":"1year","weight":0.1005},{"period":"ytd","weight":0.0997}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"City Therapeutics, Inc.于2023年7月17日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司，开发下一代RNAi疗法，旨在抑制疾病相关蛋白的表达，为有需要的患者提供有意义且持久的治疗获益。其管线聚焦于血栓栓塞性疾病、Stargardt病1型和慢性病贫血等重大未满足医疗需求。","exchange":"NASDAQ","name":"City Therapeutics","nameEN":"City Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.53.0","shortVersion":"4.53.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"City Therapeutics(CTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供City Therapeutics(CTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"City Therapeutics,CTY,City Therapeutics股票,City Therapeutics股票老虎,City Therapeutics股票老虎国际,City Therapeutics行情,City Therapeutics股票行情,City Therapeutics股价,City Therapeutics股市,City Therapeutics股票价格,City Therapeutics股票交易,City Therapeutics股票购买,City Therapeutics股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"City Therapeutics(CTY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供City Therapeutics(CTY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}